SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-12-063286
Filing Date
2012-12-10
Accepted
2012-12-10 08:00:15
Documents
2
Period of Report
2012-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CONSENT AND WAIVER rrd362679.htm 8-K 13556
2 CONSENT AND WAIVER AGREEMENT, DATED DECEMBER 7, 2012 rrd362679_38916.htm EX-10 15652
  Complete submission text file 0001181431-12-063286.txt   30376
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 121251569
SIC: 2836 Biological Products, (No Diagnostic Substances)